Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Completed × Immunotherapy × Clear all

Phase

Status

Not yet recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 1077 Carcinoma, Non-Small-Cell Lung 772 Prostatic Neoplasms 625 Neoplasms 519 Multiple Myeloma 459 Lymphoma 455 Colorectal Neoplasms 453 Lung Neoplasms 447 Leukemia 425 Neoplasm Metastasis 405 Leukemia, Myeloid, Acute 394 Melanoma 370 Lymphoma, Non-Hodgkin 344 Ovarian Neoplasms 343 Leukemia, Lymphocytic, Chronic, B-Cell 324 Pancreatic Neoplasms 320 Recurrence 292 Precursor Cell Lymphoblastic Leukemia-Lymphoma 268 Glioblastoma 256 Lymphoma, Large B-Cell, Diffuse 252 Head and Neck Neoplasms 252 Brain Neoplasms 247 Stomach Neoplasms 244 Myelodysplastic Syndromes 244 Lymphoma, Follicular 237 Carcinoma, Renal Cell 227 Rectal Neoplasms 220 Carcinoma, Hepatocellular 217 Hodgkin Disease 215 Sarcoma 211

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04225390 2026-02-10

PROMIT

University of Erlangen-Nürnberg Medical School

Phase 2 Completed

Immunotherapy

Data powered by HemOnc (CC BY 4.0) Colophon ⚡